| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |